On May 22, 2025, NBD Healthcare Co., Ltd. had the distinct honor of welcoming Mr. Nobuhiro Torii, President of Suntory Holdings, together with three senior executives from the Suntory Group: Mr. Toru Miyanaga (SHD Managing Director), Mr. Masato Hayashi (SGS APAC President), and Mr. Naoyuki Ogushi (SHD Chief of Staff to the President).

This important visit underscored the robust collaboration between our teams and reflected the professional work environment we have continuously fostered and refined. The distinguished guests were warmly received by NBD’s executive team, led by Mr. Somsak Kaveetriphop (NBD Managing Director), Mr. Mario Suzuki (SWE APAC CEO / NBD Chairman), Mr. Atsushi Ito (SWE APAC CSO / NBD Head of Strategy), Mr. Junichi Sakai (SWE APAC CFO), Mr. Makoto Ise (NBD Head of Finance), Ms. Kunyaphat Sitthikhunkitt (NBD Head of Marketing), and Ms. Pirada Limparnartphaisan (NBD Head of P&C).

During this special occasion, NBD’s leadership team presented key updates on the company’s progress, post-acquisition achievements, and the strategic roadmap for 2025, which greatly captured the interest of the Suntory executives.

Additionally, the Suntory delegation was given an insightful tour of Pronova Laboratories Co., Ltd., NBD’s cutting-edge manufacturing facility renowned for its innovation and highest standards, as well as a market visit that reaffirmed NBD’s leadership in the health and beauty supplement industry.

On behalf of NBD Healthcare Co., Ltd., we extend our heartfelt gratitude to Mr. Nobuhiro Torii and the Suntory executive team for their visit. Their presence serves as a powerful encouragement and a driving force for us to move forward with confidence, creating shared value and success together in the future.